NASDAQ : MGNX
MacroGenics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.38 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 151.61M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
MacroGenics, Inc. (MGNX) reported revenue of 175.14M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 175.14M | 149.50M | 149.96M | 58.75M | 151.94M | 77.45M |
| Cost of Revenue | 176.45M | 183.18M | 189.49M | 174.81M | 214.41M | 217.23M |
| Gross Profit | -1.30M | -33.68M | -39.53M | -116.06M | -62.47M | -139.78M |
| Selling, General & Admin | 36.75M | 39.16M | 71.05M | 52.19M | 58.95M | 63.01M |
| Operating Expenses | 36.75M | 39.16M | 71.05M | 52.19M | 58.95M | 63.01M |
| Operating Income | -38.06M | -72.84M | -110.58M | -168.24M | -121.42M | -202.79M |
| Interest Expense | -16.90M | -8.51M | -1.11M | -1.43M | ||
| Interest & Investment Income | 5.89M | 6.06M | 9.42M | 9.69M | 1.66M | 680.00K |
| Other Non Operating Income (Expenses) | 150.93M | |||||
| EBT Excluding Unusual Items | -49.07M | -75.29M | -102.27M | -9.06M | -119.76M | -202.12M |
| Gain (Loss) on Sale of Assets | 36.25M | |||||
| Pretax Income | -101.83M | -75.29M | -66.02M | -9.06M | -119.76M | -202.12M |
| Income Tax Expense | -777.00K | -672.00K | 944.00K | |||
| Net Income | -14.59M | -74.62M | -66.97M | -9.06M | -119.76M | -202.12M |
| Net Income to Common | -14.59M | -74.62M | -66.97M | -9.06M | -119.76M | -202.12M |
| Shares Outstanding (Basic) | 63.39M | 63.16M | 62.62M | 61.93M | 61.43M | 59.94M |
| Shares Outstanding (Diluted) | 63.39M | 63.16M | 62.62M | 61.93M | 61.43M | 59.94M |
| EPS (Basic) | -0.23 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
| EPS (Diluted) | -0.23 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
| Free Cash Flow | -65.54M | -82.95M | -72.08M | -79.97M | -90.58M | -150.03M |
| Free Cash Flow Per Share | -1.03 | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 |
| Gross Margin | -0.74% | -22.53% | -26.36% | -197.54% | -41.11% | -180.49% |
| Operating Margin | -21.73% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
| Profit Margin | -8.33% | -49.91% | -44.66% | -15.42% | -78.82% | -260.97% |
| Free Cash Flow Margin | -37.42% | -55.49% | -48.07% | -136.12% | -59.62% | -193.72% |
| EBITDA | -32.17M | -65.67M | -103.04M | -158.60M | -109.55M | -191.54M |
| EBITDA Margin | -18.37% | -43.93% | -68.71% | -269.96% | -72.10% | -247.31% |
| D&A For EBITDA | 5.89M | 7.17M | 7.54M | 9.64M | 11.87M | 11.26M |
| EBIT | -38.06M | -72.84M | -110.58M | -168.24M | -121.42M | -202.79M |
| EBIT Margin | -21.73% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
| Revenue as Reported | 175.14M | 149.50M | 149.96M | 58.75M | 151.94M | 77.45M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 113.91M | 57.22M | 182.84M | 100.96M | 108.88M | 123.47M |
| Short-Term Investments | 59.40M | 132.70M | 18.83M | 128.85M | 45.46M | 120.15M |
| Cash & Short-Term Investments | 173.31M | 189.91M | 201.67M | 229.81M | 154.35M | 243.62M |
| Receivables | 144.17M | 13.37M | 4.31M | 10.37M | 56.22M | 10.39M |
| Inventory | 7.91M | 1.22M | 1.45M | 4.39M | ||
| Prepaid Expenses | 4.21M | 8.74M | 11.51M | 9.95M | 10.16M | 21.17M |
| Total Current Assets | 321.69M | 219.94M | 217.49M | 251.34M | 222.18M | 279.56M |
| Property, Plant & Equipment | 23.53M | 35.52M | 42.61M | 45.69M | 56.91M | 54.29M |
| Other Long-Term Assets | 195.00K | 1.39M | 1.56M | 1.39M | 1.38M | 1.40M |
| Total Assets | 345.41M | 256.85M | 261.65M | 298.42M | 280.47M | 335.25M |
| Accounts Payable | 3.44M | 4.79M | 5.01M | 6.44M | 4.90M | 15.50M |
| Accrued Expenses | 29.90M | 22.23M | 29.33M | 24.24M | 29.00M | 33.76M |
| Current Portion of Leases | 4.98M | 5.18M | 4.86M | 3.77M | 4.73M | 4.68M |
| Current Unearned Revenue | 55.50M | 10.92M | 16.32M | 21.65M | 9.99M | 20.65M |
| Other Current Liabilities | 14.99M | |||||
| Total Current Liabilities | 108.81M | 43.12M | 55.53M | 56.11M | 48.61M | 74.58M |
| Long-Term Leases | 30.12M | 31.59M | 32.60M | 30.20M | 30.11M | 20.79M |
| Long-Term Unearned Revenue | 55.50M | 55.50M | 59.24M | 59.48M | ||
| Other Long-Term Liabilities | 163.60M | 71.05M | 1.97M | 258.00K | 258.00K | 258.00K |
| Total Liabilities | 302.54M | 201.25M | 145.60M | 145.81M | 138.46M | 95.63M |
| Common Stock | 637.00K | 633.00K | 628.00K | 621.00K | 617.00K | 613.00K |
| Additional Paid-In Capital | 1.30B | 1.30B | 1.29B | 1.25B | 1.24B | 1.21B |
| Retained Earnings | -1.26B | -1.24B | -1.17B | -1.10B | -1.09B | -973.94M |
| Comprehensive Income & Other | -15.00K | 32.00K | 4.00K | -6.00K | -5.00K | -61.00K |
| Shareholders' Equity | 42.87M | 55.59M | 116.06M | 152.61M | 142.01M | 239.62M |
| Total Liabilities & Equity | 345.41M | 256.85M | 261.65M | 298.42M | 280.47M | 335.25M |
| Total Debt | 35.09M | 36.76M | 37.46M | 33.97M | 34.83M | 25.47M |
| Net Cash (Debt) | 138.21M | 153.15M | 164.21M | 195.83M | 119.51M | 218.15M |
| Net Cash Per Share | 2.18 | 2.42 | 2.62 | 3.16 | 1.95 | 3.64 |
| Filing Date Shares Outstanding | 63.70M | 63.56M | 63.09M | 62.43M | 61.84M | 61.32M |
| Total Common Shares Outstanding | 63.65M | 63.32M | 62.82M | 62.07M | 61.70M | 61.31M |
| Working Capital | 212.87M | 176.83M | 161.96M | 195.23M | 173.57M | 204.98M |
| Book Value Per Share | 0.67 | 0.88 | 1.85 | 2.46 | 2.30 | 3.91 |
| Tangible Book Value | 42.87M | 55.59M | 116.06M | 152.61M | 142.01M | 239.62M |
| Tangible Book Value Per Share | 0.67 | 0.88 | 1.85 | 2.46 | 2.30 | 3.91 |
| Machinery | 51.73M | 50.55M | 50.75M | 50.73M | 49.35M | |
| Construction In Progress | 371.00K | 1.22M | 1.11M | 356.00K | 630.00K | |
| Leasehold Improvements | 45.02M | 44.10M | 48.62M | 52.97M | 51.06M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -14.59M | -74.62M | -66.97M | -9.06M | -119.76M | -202.12M |
| Depreciation & Amortization | 5.89M | 7.17M | 7.54M | 9.64M | 11.87M | 11.26M |
| Loss (Gain) From Sale of Assets | -94.50M | -10.00K | -36.31M | 111.00K | ||
| Loss (Gain) From Sale of Investments | -2.34M | -1.65M | -2.81M | -5.00M | 403.00K | 1.61M |
| Stock-Based Compensation | 10.83M | 14.29M | 29.44M | 18.37M | 20.44M | 23.13M |
| Other Operating Activities | 49.59M | 2.11M | -661.00K | -145.59M | 6.22M | 4.72M |
| Change in Accounts Receivable | -23.84M | -9.06M | 6.06M | 45.85M | -45.84M | 12.70M |
| Change in Inventory | 123.00K | -7.91M | -2.19M | 230.00K | 55.00K | -6.42M |
| Change in Accounts Payable | 126.00K | -280.00K | -1.53M | 1.28M | -10.86M | 7.12M |
| Change in Unearned Revenue | 77.00K | -5.40M | -9.41M | 11.43M | 48.82M | 9.26M |
| Change in Other Net Operating Assets | 4.91M | -5.68M | 8.47M | -5.48M | 1.69M | -5.09M |
| Operating Cash Flow | -63.72M | -81.04M | -68.37M | -78.20M | -86.96M | -143.83M |
| Capital Expenditures | -1.82M | -1.91M | -3.71M | -1.76M | -3.62M | -6.20M |
| Sale of Property, Plant & Equipment | 11.00K | 11.00K | 160.00K | 64.00K | ||
| Investment in Securities | -11.27M | -112.19M | 112.84M | -78.38M | 74.34M | -30.41M |
| Other Investing Activities | 40.00M | |||||
| Investing Cash Flow | -13.08M | -114.10M | 149.30M | -80.08M | 70.72M | -36.61M |
| Issuance of Common Stock | 247.00K | 129.00K | 3.44M | 1.17M | 1.66M | 122.78M |
| Repurchase of Common Stock | -224.00K | -288.00K | -2.48M | -306.00K | ||
| Other Financing Activities | 60.00M | 69.67M | 149.50M | |||
| Financing Cash Flow | 60.02M | 69.51M | 960.00K | 150.36M | 1.66M | 122.78M |
| Net Cash Flow | -16.78M | -125.62M | 81.88M | -7.93M | -14.59M | -57.66M |
| Free Cash Flow | -65.54M | -82.95M | -72.08M | -79.97M | -90.58M | -150.03M |
| Free Cash Flow Margin | -37.42% | -55.49% | -48.07% | -136.12% | -59.62% | -193.72% |
| Free Cash Flow Per Share | -1.03 | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 |
| Levered Free Cash Flow | -69.41M | -58.23M | -32.49M | -25.04M | -105.11M | -71.23M |
| Unlevered Free Cash Flow | -58.85M | -52.91M | -31.79M | -24.15M | -105.11M | -71.23M |
| Cash Income Tax Paid | 195.00K | 300.00K | ||||
| Change in Working Capital | -18.60M | -28.33M | 1.39M | 53.32M | -6.13M | 17.57M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 152.88M | 101.85M | 203.98M | 596.72M | 412.50M | 983.19M |
| Enterprise Value | 14.67M | -7.54M | 37.72M | 374.40M | 310.90M | 710.84M |
| Last Close Price | 2.40 | 1.61 | 3.25 | 9.62 | 6.71 | 16.05 |
| Forward PE | 23.96 | 23.96 | 23.96 | 23.96 | 23.96 | |
| PS Ratio | 0.87 | 0.68 | 1.36 | 10.16 | 2.71 | 12.70 |
| PB Ratio | 3.56 | 1.83 | 1.76 | 3.91 | 2.90 | 4.10 |
| P/TBV Ratio | 3.57 | 1.83 | 1.76 | 3.91 | 2.90 | 4.10 |
| EV/Sales Ratio | 0.08 | 0.25 | 6.37 | 2.05 | 9.18 | |
| Debt / Equity Ratio | 0.82 | 0.66 | 0.32 | 0.22 | 0.24 | 0.11 |
| Net Debt / Equity Ratio | -3.22 | -2.75 | -1.42 | -1.28 | -0.84 | -0.91 |
| Net Debt / EBITDA Ratio | 4.30 | 2.33 | 1.59 | 1.24 | 1.09 | 1.14 |
| Net Debt / FCF Ratio | 2.11 | 1.85 | 2.28 | 2.45 | 1.32 | 1.45 |
| Asset Turnover | 0.59 | 0.58 | 0.54 | 0.20 | 0.49 | 0.22 |
| Inventory Turnover | 130.84 | 73.44 | ||||
| Quick Ratio | 2.92 | 4.71 | 3.71 | 4.28 | 4.33 | 3.41 |
| Current Ratio | 2.96 | 5.10 | 3.92 | 4.48 | 4.57 | 3.75 |
| Return on Equity (ROE) | -225.85% | -86.94% | -49.85% | -6.15% | -62.76% | -75.49% |
| Return on Assets (ROA) | -8.05% | -17.56% | -24.68% | -36.33% | -24.65% | -35.50% |
| Return on Capital Employed (ROCE) | -16.10% | -34.10% | -53.60% | -69.40% | -52.40% | -77.80% |
| Earnings Yield | -9.75% | -73.27% | -32.83% | -1.52% | -29.03% | -20.56% |
| FCF Yield | -42.87% | -81.45% | -35.34% | -13.40% | -21.96% | -15.26% |
| Buyback Yield / Dilution | -0.77% | -0.85% | -1.12% | -0.81% | -2.48% | -14.31% |